Press Releases from Roots Analysis (220 total)
The Alzheimer’s disease market is anticipated to grow at an annualized rate of …
The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease
Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list of offerings.
Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and…
The glycosylation analysis services market is projected to reach nearly USD 2.5 …
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise in glycoconjugate / glycan analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Glycosylation Analysis Services Market, 2021 – 2030”
For more information, please click on the following link:
https://www.rootsanalysis.com/reports/glycosylation-analysis-services-market.html
The report features an extensive study on the current market landscape, offering an…
The progressive supranuclear palsy (PSP) therapies market, is projected to grow …
The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy
Roots Analysis is pleased to announce the publication of its recent study, titled, “Progressive Supranuclear Palsy Therapies Market, 2021-2030”
The report features an extensive study of the current market landscape, offering an informed…
The light activated therapies market is anticipated to grow at an annualized rat …
Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products
London
Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal, 2021-2030“ report to its list of offerings.
Rising prevalence of skin disorders is expected to…
Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis
Customized services, reduced cost and access to advanced technologies offered by contract research service providers, have prompted a number of pharmaceutical companies to outsource their research operations
London
Roots Analysis has announced the addition of “Pharmaceutical Contract Research Services Market, 2021-2030” report to its list of offerings.
Majority of the small companies as well as a few mid to large sized players, do not have the required capital or experience to undertake…
Novel Drug Reconstitution Systems Market, 2021-2030
Roots Analysis has announced the addition of “Novel Drug Reconstitution Systems Market, 2021-2030” report to its list of offerings.
To order this 320+ page report, which features 230 figures and 248 tables, please visit https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market.html
Key Inclusions
A detailed assessment of the current market landscape of novel drug reconstitution systems, providing information on the type of device (prefilled syringe, cartridge, infusion bags), type of chamber (dual chamber, multi chamber), physical…
The “RAS Targeting Therapies Market, 2021-2031” report features an extensive …
To order this 140+ page report, which features 95+ figures, please visit https://www.rootsanalysis.com/reports/ras-targeting-therapies-market.html
Key Inclusions
A detailed overview of the current market landscape of RAS targeting therapies, along with information on several relevant parameters, such as current status of development (marketed, clinical, pre-clinical and discovery), phase of development (phase III, phase II, phase I / II and phase I), type of molecule (biologic and small molecule), type of therapy (monotherapy and combination…
The novel ocular drug delivery devices market is projected to grow at a CAGR of …
The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approaches for safe and efficient administration of therapies to eyes
Roots Analysis has announced the addition of the “Novel Ocular Drug Delivery Devices Market, 2021 – 2030” report to its list of offerings.
Over the years, a number of companies have developed several novel and advanced drug…
The top selling biologics market is projected to be worth USD 156 billion by 203 …
Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a significant market share over the past couple of decades
Roots Analysis has announced the addition of the “Top Selling Biologics Market, 2021 – 2030” report to its list of offerings.
Over the years, around 200 biologics have been approved for the treatment of various disease indications in…
The bioprocess controllers and automation systems market is projected to be grow …
Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize and fasten the manufacturing process of biologics
Roots Analysis has announced the addition of “Bioprocess Controllers and Automation Systems Market, 2021-2030” report to its list of offerings.
The bioprocess controllers and automation systems have turned out to be a process optimization solution for the biopharmaceutical industries, overcoming…
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis
LONDON, ENGLAND, UNITED KINGDOM, October 5, 2021 /EINPresswire.com/ -- Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report…
The on-body drug delivery-related intellectual landscape report identifies and a …
Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions
Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant…
The biospecimen contract research market is projected to grow at a noteworthy pa …
In the ongoing COVID-19 pandemic, a surge in the number of research studies has been observed, presenting lucrative opportunities for biospecimen service providers having the capabilities to offer high-quality biospecimens and associated analytical services
London
Roots Analysis has announced the addition of “Biospecimen Contract Research Services Market, 2021 – 2030” report to its list of offerings.
Given the growing number of research and development initiatives in the pharmaceutical industry, and the rising number…
With over 20 approved products and several more in the pipeline, the HUMIRA® bi …
Unlike other biosimilar markets, competition among follow-on products of HUMIRA® is very high and several eager companies are attempting to carve out a share of the multibillion-dollar opportunity associated with this blockbuster product
Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.
Being one of the first biologics against anti-inflammatory diseases, HUMIRA® is considered an aberration in terms of…
The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2 …
Driven by the potential to confer safe and sustained therapeutic effects for clinical conditions unique to women, the non-hormonal therapies pipeline is growing, featuring candidates having improved risk profiles and lesser side effects
Roots Analysis has announced the addition of “Non-hormonal Therapies for Women’s Health Market 2021 – 2030” report to its list of offerings.
In pursuit of an advantageous and risk-free prospect to hormonal therapies, the success of 21 approved…
The glycosylation analysis services market is projected to reach nearly USD 2.5 …
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise in glycoconjugate/glycan analysis
London
Roots Analysis has announced the addition of “Glycosylation Analysis Services Market, 2021 – 2030” report to its list of offerings.
Profiling and in-depth characterization of glycosylated molecules in biotherapeutic and research samples require specialized equipment and focused expertise, which has prompted the research…
The continuous and semi-continuous bioprocessing market is projected to grow at …
The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-continuous manufacturing capabilities for biointensification
London
Roots Analysis has announced the addition of “Continuous and Semi-Continuous Bioprocessing Market, 2021 – 2030” report to its list of offerings.
Given the growing pipeline of biological drugs, and the rising preference for such therapeutic interventions, the demand for cost-effective biomanufacturing processes has increased. As a…
The glycosylation analysis services market is projected to reach nearly USD 2.5 …
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise in glycoconjugate / glycan analysis
London
Roots Analysis has announced the addition of “Glycosylation Analysis Services Market, 2021 – 2030” report to its list of offerings.
Profiling and in-depth characterization of glycosylated molecules in biotherapeutic and research samples require specialized equipment and focused expertise, which has prompted…
The CRISPR based therapeutics market is projected to be worth around USD 2.2 bil …
Considering its potential to intricately alter genetic DNA, the CRISPR technology is being widely used to develop viable therapeutics for the treatment of rare and complex genetic disorders, which are currently considered untreatable
Roots Analysis has announced the addition of “CRISPR based Therapeutics Market, 2021-2030” report to its list of offerings.
With over 115 candidates under development for various indications, the future of this niche market seems promising. The year 2020…
The global cell therapy packaging services market is projected to be worth USD 1 …
With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborate with players offering packaging and logistics services to ensure safe and timely supply to the patients
London
Roots Analysis has announced the addition of “Cell Therapy Packaging Products and Services Market, 2021-2030”report to its list of offerings.
Currently, more than 30 cell therapies have received marketing approvals across the world,…
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.
Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge…
The opportunity within the display library technologies and services market is p …
Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such as display-library technologies for rapid and successful screening of novel therapeutics
London
Roots Analysis has announced the addition of “Display Library Technologies and Affiliated Services Market, 2021-2030” report to its list of offerings.
Display libraries have been successfully employed for the generation of various novel therapeutics and offer certain advantages over conventional drug…
The viral and non-viral vector manufacturing market is projected to grow at an a …
The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities to manufacture viral and non-viral gene delivery solutions
London
Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its list of offerings.
Over time, ~15 cell and gene therapies have been approved across the…
The vascular disrupting agents market is projected to be worth USD 2 billion by …
Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications
London
Roots Analysis has announced the addition of “Vascular Disrupting Agents Market, 2021-2030” report to its list of offerings.
Despite multiple cancer treatment options, there is an evident unmet need for anti-cancer therapies with better efficacy and less toxicity. The vascular disrupting agents, which target the established tumor vasculature and disrupt blood…
The targeted protein degradation enabling technologies market, featuring a healt …
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare
London
Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings.
Small-molecule-induced protein degradation has been demonstrated to possess the potential to drug a broader range of proteinaceous biological targets. It involves the…
The immunocytokines market is estimated to be worth around USD 5.4 billion by 20 …
Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments without the safety concerns associated with cytokine therapies
London
Roots Analysis has announced the addition of the “Immunocytokines Market, 2021-2030” report to its list of offerings.
These engineered pharmacologically-active molecules have, so far, demonstrated better efficacy and reduced toxicity compared to conventional cytokine-based therapies. As a result, immunocytokines are…
The antibody purification services market is projected to be worth USD 2.02 bill …
Amidst the COVID-19 pandemic, there has been an evident surge in demand for standard quality antibodies for research, diagnosis and therapeutic purposes, which has presented lucrative opportunities for contract service providers having antibody purification capabilities
London
Roots Analysis has announced the addition of “Global Antibody Purification Services Market, 2021 – 2030” report to its list of offerings.
Isolation and purification of antibodies, from different sources, including serum, ascites fluid and hybridoma…
The cloud-based solutions for drug discovery, development and manufacturing mark …
The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solutions, to not only expedite associated timelines, but also cuts down overall cost
Roots Analysis has announced the addition of “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market by Type of Cloud (Private, Public and Hybrid), Type of Service (Infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Software as a Service…
The cell therapy manufacturing market is projected to reach USD 14.5 billion by …
Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of the highest valued markets within the biopharmaceutical industry
London
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (4th Edition), 2021-2030” report to its list of offerings.
Owing to the complex manufacturing processes, requirement of advanced production facilities and the growing demand for cell therapy products,…
The biopharmaceutical CROs market is projected to be worth USD 67 billion by 203 …
Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to remain competitive, flexible, and profitable in the industry
Roots Analysis has announced the addition of “Biopharmaceutical CROs Market, 2021-2030,” report to its list of offerings.
Given their numerous advantages, which include high specificity for intended molecular targets, ability to treat a myriad of disease indications, and…
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predi …
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their proprietary therapy candidates with cautious optimism
Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (3rd Edition), 2019-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
The report features an extensive study of the current market landscape of…
Growing at an annualized rate of 10%, the fragment-based drug discovery market i …
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges
London
Roots Analysis has announced the addition of the “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report to its list of offerings.
According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable…
The oligonucleotide synthesis, modification and purification services market is …
The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers
London
Roots Analysis has announced the addition of the “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030” report to its list of offerings.
In fact, several big pharma companies are known to outsource more…
The opportunity for AR / VR based digital marketing service providers in healthc …
Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies
Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well…
The antibody drug conjugates market is estimated to be worth more than 15 billio …
Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of…
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predi …
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their proprietary therapy candidates with cautious optimism
Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (3rd Edition), 2019-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
The report features an extensive study of the current market landscape of…
The drug repurposing service providers market is estimated to be worth USD 1.2 b …
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”
For more information please click on the following
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
The report features an extensive study of the current market landscape and…
The global autoinjectors market is projected to grow at an annualized rate of ov …
Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”
For more information please click on the following
https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html
The report features an extensive study of the current market landscape, offering an informed opinion…
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing mark …
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.
For additional details, please visit - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Owing to various reasons, the demand for cell therapies is…
With over 280 therapies under evaluation, the stem cell therapy market is estima …
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies,…
The subcutaneous biologic drugs and affiliated technologies market is projected …
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals
Roots Analysis is pleased to announce the publication of its recent study, titled “Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its list of offerings.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
The report provides…
The STING pathway targeting technologies market, featuring a healthy pipeline of …
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
The report features an extensive study of the current market landscape and…
The contract manufacturing market for Pharmaceuticals in China is estimated to b …
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world
Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”
For more information please click on the following
https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html
The report features an extensive study of the current market…
The Chinese biopharmaceutical contract manufacturing market is estimated to be w …
The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years
Roots Analysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical Contract Manufacturing Market, 2020-2030.”
The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of…
Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.
Owing to various reasons, the demand for cell therapies is anticipated to increase over the…
Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.
To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this…
Cell and Advanced Therapies Supply Chain Management Market, 2020-2030
The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.
To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this -
https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
The USD 1.5…
The Companion Diagnostics Development Services Market is estimated to be worth o …
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”
For more information please click on the following
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
The report features an extensive study of the…
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth US …
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”
For more information please click on the following https://www.rootsanalysis.com/reports/253/request-sample.html:
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
The report features an extensive…
The RNAi therapeutics market is anticipated to grow at an annualized rate of mor …
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research
London
Roots Analysis has announced the addition of “RNAi Therapeutics Market (2nd Edition), 2019-2030” report to its list of offerings.
Significant advancements in the developmental pipeline across various oncological disorders, infectious diseases and genetic disorders have amplified the interest of various pharmaceutical establishments and have…
